Related references
Note: Only part of the references are listed.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
Jen N. Goh et al.
BIOLOGICAL REVIEWS (2016)
Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer
Gayathri Nagaraj et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
Andrew McGuire et al.
CANCER AND METASTASIS REVIEWS (2015)
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance
Howard M. Stern et al.
CLINICAL CANCER RESEARCH (2015)
Mechanisms of hormonal therapy resistance in breast cancer
Shin-ichi Hayashi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
Estrogen Receptor Mutations Found in Breast Cancer Metastases Integrated With the Molecular Pharmacology of Selective ER Modulators
V. Craig Jordan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer
Muralidharan Anbalagan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets
Carolyn M. Klinge
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles Includes microRNA-like tRNA Fragments
Nicole Guzman et al.
MOLECULAR CANCER RESEARCH (2015)
Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer
Sanaa Eissa et al.
TRANSLATIONAL RESEARCH (2015)
MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells' growth and migration
Guo-qing Song et al.
TUMOR BIOLOGY (2015)
MicroRNA-574-3p, identified by microRNA library- based functional screening, modulates tamoxifen response in breast cancer
T. Ujihira et al.
SCIENTIFIC REPORTS (2015)
Estrogen Receptor Mutations Found in Breast Cancer Metastases Integrated With the Molecular Pharmacology of Selective ER Modulators
V. Craig Jordan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
The role of miR-200a in mammalian epithelial cell transformation
Lindsey E. Becker et al.
CARCINOGENESIS (2015)
Exosomes as divine messengers: are they the Hermes of modern molecular oncology?
C. Braicu et al.
CELL DEATH AND DIFFERENTIATION (2015)
MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells
J. Cui et al.
ONCOGENE (2015)
Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death
Hye Joung Choi et al.
BREAST CANCER RESEARCH (2015)
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
Erin L. Hayes et al.
BREAST CANCER RESEARCH (2015)
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
Eleni van Schooneveld et al.
BREAST CANCER RESEARCH (2015)
MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer
Paul Vilquin et al.
BREAST CANCER RESEARCH (2015)
Extranuclear estrogen receptor's roles in physiology: lessons from mouse models
Ellis R. Levin
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
Joaquina Martinez-Galan et al.
BMC CANCER (2014)
Molecular characterization of exosome-like vesicles from breast cancer cells
Stefan Kruger et al.
BMC CANCER (2014)
Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
Yifang Wei et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Sonia A. Melo et al.
CANCER CELL (2014)
Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3
R. Gan et al.
CANCER GENE THERAPY (2014)
Characterization of a Stem-like Subpopulation in Basal-like Ductal Carcinoma in Situ (DCIS) Lesions
Qinglin Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER plus breast cancer
Aoife Ward et al.
JOURNAL OF PATHOLOGY (2014)
ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells
Hao Deng et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Breast cancer: Current and future endocrine therapies
Carlo Palmieri et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
Ramesh Singh et al.
MOLECULAR CANCER (2014)
Mapping Argonaute and conventional RNA-binding protein interactions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS analysis
Michael J. Moore et al.
NATURE PROTOCOLS (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
miRBase: annotating high confidence microRNAs using deep sequencing data
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2014)
Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
S. S. Roy et al.
ONCOGENE (2014)
Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs
Wei-xian Chen et al.
PLOS ONE (2014)
Integrative Omic Analysis for Tamoxifen Sensitivity through Cell Based Models
Liming Weng et al.
PLOS ONE (2014)
MicroRNA-7 Inhibits Multiple Oncogenic Pathways to Suppress HER2Δ16 Mediated Breast Tumorigenesis and Reverse Trastuzumab Resistance
Felicia C. Huynh et al.
PLOS ONE (2014)
The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulators
V. Craig Jordan et al.
STEROIDS (2014)
MicroRNAs delivered by extracellular vesicles: an emerging resistance mechanism for breast cancer
Wei-xian Chen et al.
TUMOR BIOLOGY (2014)
MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells
Hong-Lei Jiang et al.
TUMOR BIOLOGY (2014)
Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer
In Hae Park et al.
TUMOR BIOLOGY (2014)
Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs
Wei-xian Chen et al.
TUMOR BIOLOGY (2014)
Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
Corinna Eichelser et al.
ONCOTARGET (2014)
Clinical significance of epithelial-mesenchymal transition
Konrad Steinestel et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2014)
Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer
Meng Zhao et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
Anna Bergamaschi et al.
BREAST CANCER RESEARCH (2014)
Estrogen receptor signaling as a target for novel breast cancer therapeutics
Jack-Michel Renoir et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Cellular functions of the microprocessor
Sara Macias et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients
Sarkawt M. Khoshnaw et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Endocrine Resistance in Breast Cancer: Focus on the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway
Shira Peleg Hasson et al.
BREAST CARE (2013)
Role of microRNAs in breast cancer
Ramesh Singh et al.
CANCER BIOLOGY & THERAPY (2013)
Binding of intronic miRNAs to the mRNAs of host genes encoding intronic miRNAs and proteins that participate in tumourigenesis
O. Berillo et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2013)
Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment
Reiner Hoppe et al.
EUROPEAN JOURNAL OF CANCER (2013)
Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells
Guangliang Li et al.
MOLECULAR ONCOLOGY (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
A. Ward et al.
ONCOGENE (2013)
Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
Tissa T. Manavalan et al.
PLOS ONE (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells
Jong-Kuen Lee et al.
PLOS ONE (2013)
Regulation of estrogen receptor a by histone methyltransferase SMYD2-mediated protein methylation
Xi Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
PROmiRNA: a new miRNA promoter recognition method uncovers the complex regulation of intronic miRNAs
Annalisa Marsico et al.
GENOME BIOLOGY (2013)
Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells
Deborah A. Sanders et al.
GENOME BIOLOGY (2013)
Hypoxic enhancement of exosome release by breast cancer cells
Hamish W. King et al.
BMC CANCER (2012)
Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs
I. K. Guttilla et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Loss of Dicer expression is associated with breast cancer progression and recurrence
Sarkawt M. Khoshnaw et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients
Eun-Jung Jung et al.
CANCER (2012)
Microparticles and their emerging role in cancer multidrug resistance
J. Gong et al.
CANCER TREATMENT REVIEWS (2012)
Dicer Partner Proteins Tune the Length of Mature miRNAs in Flies and Mammals
Ryuya Fukunaga et al.
CELL (2012)
Steroid receptor coactivator-3 as a potential molecular target for cancer therapy
Jean Ching-Yi Tien et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Influence of Berry Polyphenols on Receptor Signaling and Cell-Death Pathways: Implications for Breast Cancer Prevention
Harini S. Aiyer et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
The miR-200 and miR-221/222 microRNA Families: Opposing Effects on Epithelial Identity
Erin N. Howe et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2012)
Significance of PELP1 in ER-Negative Breast Cancer Metastasis
Sudipa Roy et al.
MOLECULAR CANCER RESEARCH (2012)
MicroRNAs are exported from malignant cells in customized particles
Jaime Palma et al.
NUCLEIC ACIDS RESEARCH (2012)
Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
A. Bergamaschi et al.
ONCOGENE (2012)
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways
I. Keklikoglou et al.
ONCOGENE (2012)
Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells
XinTian Zhang et al.
PLOS ONE (2012)
Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-αi and caveolin I
Cheryl S. Watson et al.
STEROIDS (2012)
miRNAs and estrogen action
Carolyn M. Klinge
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells
Lorenzo Ferraro et al.
HORMONES & CANCER (2012)
Mechanisms of Endocrine Resistance in Breast Cancer
C. Kent Osborne et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer
F. German Rodriguez-Gonzalez et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells
Tissa T. Manavalan et al.
CANCER LETTERS (2011)
MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer
Wei Shi et al.
CANCER RESEARCH (2011)
microRNAs as novel epigenetic biomarkers for human cancer
Maria Cortes-Sempere et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer Cells
Jennifer Selever et al.
CLINICAL CANCER RESEARCH (2011)
被撤回的出版物: Anti-microRNA-222 (Anti-miR-222) and-181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal (Retracted article. See vol. 293, pg. 3588, 2018)
Yuanzhi Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
Mei Yang et al.
MOLECULAR CANCER (2011)
Alternative miRNA Biogenesis Pathways and the Interpretation of Core miRNA Pathway Mutants
Jr-Shiuan Yang et al.
MOLECULAR CELL (2011)
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up
Meredith M. Regan et al.
LANCET ONCOLOGY (2011)
let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer
Yingchun Zhao et al.
MOLECULAR MEDICINE (2011)
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Eric Huntzinger et al.
NATURE REVIEWS GENETICS (2011)
MicroRNA-101-mediated Akt activation and estrogen-independent growth
M. Sachdeva et al.
ONCOGENE (2011)
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
X. Rao et al.
ONCOGENE (2011)
Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
Francoise Rothe et al.
PLOS ONE (2011)
The different roles of ER subtypes in cancer biology and therapy
Christoforos Thomas et al.
NATURE REVIEWS CANCER (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells
Selma Masri et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Oncogenic HER2δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
Diana M. Cittelly et al.
CARCINOGENESIS (2010)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
New Strategies in Estrogen Receptor-Positive Breast Cancer
Stephen R. D. Johnston
CLINICAL CANCER RESEARCH (2010)
Proinflammatory Cytokines Enhance Estrogen-dependent Expression of the Multidrug Transporter Gene ABCG2 through Estrogen Receptor and NFκB Cooperativity at Adjacent Response Elements
Madhumita Pradhan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Mitch Dowsett et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Diana M. Cittelly et al.
MOLECULAR CANCER (2010)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
Jack Cuzick et al.
LANCET ONCOLOGY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle
Ramesh Narayanan et al.
PLOS ONE (2010)
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Lucy Pigati et al.
PLOS ONE (2010)
MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer
Dawn R. Cochrane et al.
Hormones & Cancer (2010)
MicroRNAs and their target gene networks in breast cancer
Elizabeth O'Day et al.
BREAST CANCER RESEARCH (2010)
Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance
Fuxiao Xin et al.
BIOINFORMATICS (2009)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target
R. J. Santen et al.
ENDOCRINE REVIEWS (2009)
Argonaute-2 Expression Is Regulated by Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling and Correlates with a Transformed Phenotype in Breast Cancer Cells
Brian D. Adams et al.
ENDOCRINOLOGY (2009)
Exosomes: proteomic insights and diagnostic potential
Richard J. Simpson et al.
EXPERT REVIEW OF PROTEOMICS (2009)
MicroRNA target prediction by expression analysis of host genes
Vincenzo Alessandro Gennarino et al.
GENOME RESEARCH (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
Liang Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?
Ciara S. O'Brien et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance
Doyel Mitra et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Biogenesis of small RNAs in animals
V. Narry Kim et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: Molecular mechanism and clinical implications for endocrine therapy resistance
Grazia Arpino et al.
ENDOCRINE REVIEWS (2008)
MicroRNA-221/222 Negatively Regulates Estrogen Receptor α and Is Associated with Tamoxifen Resistance in Breast Cancer
Jian-Jun Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Tyler E. Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNAs accurately identify cancer tissue origin
Nitzan Rosenfeld et al.
NATURE BIOTECHNOLOGY (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor
Edward J. Filardo et al.
STEROIDS (2008)
Overcoming endocrine resistance in breast cancer-are signal transduction inhibitors the answer?
Philippe L. Bedard et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Re-evaluation of mammary stem cell biology based on in vivo transplantation
Gilbert H. Smith et al.
BREAST CANCER RESEARCH (2008)
The role of microRNAs in cancer: No small matter
Erik A. C. Wiemer
EUROPEAN JOURNAL OF CANCER (2007)
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor
Rajib Rajhans et al.
CANCER RESEARCH (2007)
Enhanced NFκB and AP-I transcriptional activity associated with antiestrogen resistant breast cancer
Yamei Zhou et al.
BMC CANCER (2007)
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
L. Perey et al.
ANNALS OF ONCOLOGY (2007)
Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
Gregory J. Hurteau et al.
CANCER RESEARCH (2007)
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer
V. Craig Jordan et al.
STEROIDS (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA
Anwar Hossain et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
A variant of estrogen receptor-α, hER-α36:: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling
ZY Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Sumoylation of the estrogen receptor α hinge region regulates its transcriptional activity
S Sentis et al.
MOLECULAR ENDOCRINOLOGY (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing
TP Chendrimada et al.
NATURE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Aromatase inhibitors: Combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance
SRD Johnston et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes
S Baskerville et al.
RNA (2005)
S-palmitoylation modulates human estrogen receptor-α functions
F Acconcia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
DM Brown et al.
CANCER CELL (2004)
Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs
MT Bohnsack et al.
RNA (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells
SS Nair et al.
CANCER RESEARCH (2004)
The Drosha-DGCR8 complex in primary microRNA processing
JJ Han et al.
GENES & DEVELOPMENT (2004)
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
G Meister et al.
MOLECULAR CELL (2004)
Estrogen receptor mutations in human disease
MH Herynk et al.
ENDOCRINE REVIEWS (2004)
Identification of mammalian microRNA host genes and transcription units
A Rodriguez et al.
GENOME RESEARCH (2004)
Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc
F Barletta et al.
MOLECULAR ENDOCRINOLOGY (2004)
Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
R Clarke et al.
ONCOGENE (2003)
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
LA Doyle et al.
ONCOGENE (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells
L Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Proximal events in signaling by plasma membrane estrogen receptors
M Razandi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tumor necrosis factor signaling
H Wajant et al.
CELL DEATH AND DIFFERENTIATION (2003)
Estrogen receptor α and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells
LN Petz et al.
ENDOCRINOLOGY (2002)
Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1
L Liao et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Mechanisms of tamoxifen-induced apoptosis
S Mandlekar et al.
APOPTOSIS (2001)
Tumor necrosis factor receptor-associated factors (TRAFs)
JR Bradley et al.
ONCOGENE (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells
HJ List et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry
A Clayton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo
R Schiff et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
